Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prime Medicine, Inc. | 1,300,000 | reported | 26 Feb 2026 | tx 10+5,400,000−850,000 |
| PALVELLA THERAPEUTICS, INC. | 162,500 | reported | 26 Feb 2019 | tx 6+781,333 |
| Foghorn Therapeutics Inc. | 90,000 | reported | 26 Jan 2023 | tx 5+398,784 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | GRANT_AWARD | Prime Medicine, Inc. | 1,300,000 | 0.00 USD | deriv |
| 01 Aug 2025 | OTHER | Prime Medicine, Inc. | 850,000 | — | deriv |
| 01 Aug 2025 | GRANT_AWARD | Prime Medicine, Inc. | 850,000 | — | deriv |
| 21 May 2025 | PURCHASE | Prime Medicine, Inc. | 125,000 | 1.18 USD | first after silence |
| 19 May 2025 | GRANT_AWARD | Prime Medicine, Inc. | 2,000,000 | 0.00 USD | deriv |
| 08 May 2025 | GRANT_AWARD | Prime Medicine, Inc. | 75,000 | 0.00 USD | deriv |
| 27 Feb 2025 | GRANT_AWARD | Prime Medicine, Inc. | 275,000 | 0.00 USD | deriv |
| 05 Dec 2024 | GRANT_AWARD | Prime Medicine, Inc. | 75,000 | 0.00 USD | deriv |
| 17 May 2024 | GRANT_AWARD | Prime Medicine, Inc. | 100,000 | 0.00 USD | deriv |
| 17 Jan 2024 | GRANT_AWARD | Prime Medicine, Inc. | 600,000 | 0.00 USD | deriv |
| 26 Jan 2023 | GRANT_AWARD | Foghorn Therapeutics Inc. | 90,000 | 0.00 USD | deriv |
| 26 Jan 2022 | GRANT_AWARD | Foghorn Therapeutics Inc. | 135,000 | 0.00 USD | deriv |
| 09 Aug 2021 | EXERCISE | Foghorn Therapeutics Inc. | 26,892 | 3.72 USD | |
| 09 Aug 2021 | EXERCISE | Foghorn Therapeutics Inc. | 26,892 | 0.00 USD | deriv |
| 28 Jan 2021 | GRANT_AWARD | Foghorn Therapeutics Inc. | 120,000 | 0.00 USD | deriv |
| 26 Feb 2019 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 162,500 | 0.00 USD | deriv |
| 20 Feb 2018 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 53,833 | 0.00 USD | deriv |
| 20 Feb 2018 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 17 Aug 2017 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 20,000 | 4.89 USD | |
| 16 Aug 2017 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 45,000 | 4.79 USD | |
| 09 Aug 2017 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 450,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 21 May 2025.